HEMATOLOGIC DISEASES
Clinical trials for HEMATOLOGIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC DISEASES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cancer drug stop transplant rejection in kids?
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can lower the chance of graft-versus-host disease (GVHD) in children, teens, and young adults getting a bone marrow or blood stem cell transplant for blood cancers. About 43 participants will receive vorinostat …
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:40 UTC
-
CRISPR gene therapy: a lifelong watch begins for blood disease patients
Disease control ENROLLING_BY_INVITATIONThis study follows 160 children and adults with beta-thalassemia or sickle cell disease who already received an experimental CRISPR gene therapy called CTX001. Researchers will track participants for years to check for long-term side effects, new cancers, and how well the treatme…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
CRISPR gene therapy may free kids with thalassemia from lifelong transfusions
Disease control OngoingThis study tests a single dose of CTX001, a gene therapy made from the patient's own blood stem cells edited with CRISPR, in 16 children with transfusion-dependent beta-thalassemia. The goal is to see if it can help them produce enough healthy red blood cells to stop needing regu…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
ITP drug study halted before it began
Disease control TerminatedThis study was designed to test an experimental drug called HMPL-523 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The goal was to see if the drug is safe and can raise platelet counts. However, th…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
Muscle weakness may predict transplant success in blood cancer patients
Knowledge-focused OngoingThis study looks at how blood cancers and stem cell transplants affect muscle function in 144 patients. Researchers want to see if muscle health can help predict complications like infections, relapse, or survival. The goal is to better understand the role of muscle strength at k…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC
-
Massive study tracks health of 33,000 gulf oil spill Clean-Up workers
Knowledge-focused OngoingThis study follows over 32,000 people who helped clean up the 2010 Deepwater Horizon oil spill or lived in affected areas. Researchers compare their health to people who were not exposed, using medical exams, lab tests, and phone interviews every two years. The goal is to learn a…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 26, 2026 05:46 UTC
-
Frozen testicle tissue may one day help men have children after cancer treatment
Knowledge-focused OngoingThis small study tests whether frozen testicular tissue can be transplanted back into men to produce sperm. It includes men with infertility and healthy volunteers. The goal is to see if this approach could one day preserve fertility for boys who lose it due to cancer treatment.
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Herlev and Gentofte Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:44 UTC
-
New digital platform aims to cut errors when patients are transferred between hospitals
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new digital platform that helps hospitals share patient information more reliably when a patient is transferred from one hospital to another. About 1,000 adults being moved to Brigham and Women's Hospital from three other hospitals will take part. The goal is t…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:42 UTC
-
Massive data collection aims to spark new medical discoveries
Knowledge-focused ENROLLING_BY_INVITATIONThis study gathers medical information from up to 10,000 people with blood or lung conditions, as well as stem cell donors. Researchers will review participants' medical records, test results, and treatments to build a database for future research ideas. The goal is not to test a…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC
-
Scientists seek tissue samples to unlock cancer secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and tissue samples from people receiving bone marrow transplants and their donors. Researchers will analyze these samples to find genes and proteins linked to cancer. The goal is to better understand why some patients develop complications or have differ…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC